How is myelodysplastic syndromes treated?

Some people have regular blood tests and examinations while the team watches for changes. Supportive care may include blood transfusion support for low red cells or platelets, and growth factor support to encourage production of particular blood cells. Medicines may be used to improve blood counts or control abnormal marrow cells.

An allogeneic stem cell transplant uses stem cells from a donor and can offer a potentially long-term disease-control approach for selected people. It involves conditioning treatment and careful monitoring for infection and graft-versus-host disease. The team also considers whether the condition has features linked with acute myeloid leukaemia, because this can change the treatment plan.

Attend scheduled blood tests and tell the team about easy bruising, bleeding, persistent fatigue, fever or breathlessness. Reduce injury risks if platelets are low, and check before taking medicines that affect bleeding. Ask how to respond to a temperature rise, when transfusion support is needed and whether a donor search should begin.

Seek urgent care for heavy bleeding, black stools, severe headache after an injury, chest pain, major breathlessness or fainting. Contact your team promptly for fever, chills, rapidly spreading bruises or marked weakness. Low blood counts can make infection, bleeding and anaemia more serious, even when symptoms begin mildly.

What do my marrow and blood results show? Is observation reasonable, or should treatment start now? Which support would help my blood counts? What are the aims and burdens of an allogeneic transplant? How will you monitor for progression or infection?